CT-P10

rituximab biosimilar · Celltrion

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for CT-P10, covering 2014-07-23 to 2021-04-08. Get the full timeline:

Most recent: Clinical Trial Update: To Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular Lymphoma [Phase 3]

See pricing